Hangzhou Outai Biotechnology has repurchased shares amounting to 1.03%, with a total expenditure of 54.5094 million yuan.

Log in to Sina Finance App and search for [Information Disclosure] to see more evaluation levels.

On March 19, Hangzhou Aotai Biotechnology Co., Ltd. (hereinafter referred to as “Aotai Biotech”) announced that as of March 18, 2026, the company has repurchased a total of 820,500 shares through centralized bidding, accounting for 1.03% of the total share capital, with a total payment of 54.5094 million yuan (excluding transaction fees).

Basic Information of the Repurchase Plan

Aotai Biotech held the 19th meeting of the third board of directors and the first extraordinary general meeting of 2026 on January 21 and February 6, respectively, and approved the share repurchase plan. According to the plan, the company intends to use the proceeds from the initial public offering exceeding the funds needed, to repurchase shares through Shanghai Stock Exchange’s centralized bidding, all for cancellation to reduce registered capital.

The plan indicates that the maximum repurchase price will not exceed 85 yuan per share (including), with a total repurchase fund range of 100 million to 200 million yuan. The repurchase period is 12 months from the date of shareholder approval, from February 9, 2026, to February 8, 2027.

Progress of the Repurchase

According to the announcement, as of March 18, 2026, the highest transaction price for completed repurchases was 68.29 yuan/share, and the lowest was 64.05 yuan/share. The company has repurchased 820,500 shares, accounting for 1.03% of the total share capital of 79,280,900 shares, with a total payment of 54.5094 million yuan. Based on this, the current repurchase amount has reached 54.51% of the lower limit of the estimated 100 million yuan.

The company stated that the repurchased shares comply with legal regulations and the requirements of the repurchase plan.

Follow-up Arrangements

Aotai Biotech pointed out in the announcement that it will strictly follow the “Rules for Share Repurchase of Listed Companies,” “Guidelines for Self-Regulation of Listed Companies on the Shanghai Stock Exchange No. 7—Share Repurchase,” and other regulations. During the repurchase period, the company will implement repurchases based on market conditions and fulfill information disclosure obligations in a timely manner. Investors should be aware of related investment risks.

Disclaimer: The market carries risks; investments should be cautious. This article is automatically published by an AI large model based on third-party databases and does not represent Sina Finance’s views. Any information appearing in this article is for reference only and does not constitute personal investment advice. Please refer to the actual announcement for any discrepancies. If you have questions, contact biz@staff.sina.com.cn.

Click to view the original announcement>>

Massive information, precise interpretation, all on Sina Finance App.

Editor: Xiao Lang Kuai Bao